Q9980 Hyaluronan – HCPCS Reimbursement Benchmarks

HCPCS Level II code Q9980 denotes a unit of hyaluronan derivative (Genvisc 850) for intra-articular injection, billed per 1 mg. This supply-level code is relevant for clinicians, billing teams, and payers involved in musculoskeletal care, particularly osteoarthritis management where viscosupplementation is used to improve joint lubrication and reduce pain. Nationally, accurate coding of injectable hyaluronans affects coverage decisions, claims processing, and aggregate spending on joint injection therapies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for Q9980, typical sites of service, and the role of this HCPCS Level II code in billing workflows. The publication also outlines the types of benchmarks and policy-relevant considerations readers can expect, including utilization and reimbursement patterns, coding clarity for supply items versus procedural components, and potential payer coverage variations. Data limitations and item-level details are noted where source information is unavailable.

Billing Code Overview

HCPCS Level II code Q9980 represents hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg. This item is a single-unit injectable medical supply intended for intra-articular use to supplement joint lubrication and cushioning.

Service Type: Intra-articular hyaluronan injectable

Typical Site of Service: Outpatient clinic, physician office, or ambulatory surgical center for joint injection procedures

Data not available in the input.

Clinical Context

A typical patient is a middle-aged to older adult presenting to an orthopedic or sports medicine clinic with symptomatic osteoarthritis of the knee causing persistent joint pain and functional limitation despite conservative care (activity modification, physical therapy, oral analgesics, and intra-articular corticosteroid injections). The clinician confirms the diagnosis by history, physical exam (joint line tenderness, crepitus, reduced range of motion), and imaging (weight-bearing radiographs showing joint-space narrowing or MRI when indicated). After shared decision-making, the provider performs an intra-articular viscosupplementation injection using a hyaluronan derivative product billed under Q9980 (Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg).

Workflow steps:

Patient arrival, verification of identity and consent for an intra-articular injection.
Pre-procedure assessment documenting indication, prior treatments, allergies, anticoagulation status, and a focused knee exam.
Preparation of the sterile field and medication; optional topical or local anesthesia.
Procedure: landmark- or image-guided intra-articular injection of the hyaluronan product into the knee joint; documentation of laterality and number of injections administered during the visit.
Post-procedure observation for immediate adverse events and discharge instructions including activity restrictions and follow-up plan.
Billing: drug/service billed with HCPCS Level II code Q9980 for the administered hyaluronan product; appropriate CPT procedure codes for the injection and guidance, if performed, are reported separately.

Coding Specifications

Modifier	Description	When to Use
`24`	Unrelated Evaluation and Management Service by the Same Physician During a Postoperative Period	Use when a separate unrelated E/M visit occurs on the same day as the injection during a global postoperative period.
`25`	Significant, Separately Identifiable E/M Service by the Same Physician on the Day of a Procedure	Use when a documented E/M visit is distinct from the injection visit and meets E/M criteria.
`26`	Professional Component	Use when billing only the professional interpretation component of an image-guided injection separately from facility charges.
`50`	Bilateral Procedure	Use when bilateral knee injections are performed and payor requires bilateral modifier reporting.
`59`	Distinct Procedural Service	Use to indicate a distinct procedural service when another procedure was performed the same day and not normally reported together.
`76`	Repeat Procedure by Same Physician	Use when the same injection procedure is repeated later the same day by the same provider.
`77`	Repeat Procedure by Another Physician	Use when a repeat injection procedure is performed by a different physician the same day.
`GH`	Service Rendered: Request Not Medically Necessary	Rarely used; applicable per specific payor policies when prior authorization was requested but not approved (follow payor rules).
`JW`	Drug or Biological Amount Discarded/Not Administered to Any Patient	Use when partial vial wastage of the hyaluronan product occurs and documentation of discarded amount is required.
`XE`	Separate Encounter, A Service That Is Distinct Because It Occurred During a Separate Encounter	Use to show a service was provided during a different encounter from other services if applicable.

Taxonomy Code	Specialty	Notes
`2080P0207X`	Orthopedic Surgery	Orthopedic surgeons commonly perform knee viscosupplementation.
`207X00000X`	Physical Medicine & Rehabilitation	PM&R physicians treat osteoarthritis and perform intra-articular injections.
`2084P0809X`	Sports Medicine	Sports medicine physicians provide joint injections for degenerative and post-traumatic joints.
`363A00000X`	Rheumatology	Rheumatologists may perform injections for inflammatory and degenerative joint disease.
`207L00000X`	Pain Medicine	Pain physicians perform image-guided joint injections as part of multimodal pain management.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M17.0`	Bilateral primary osteoarthritis of knee	Common indication for viscosupplementation for symptomatic knee OA when conservative care has failed.
`M17.11`	Unilateral primary osteoarthritis, right knee	Used when viscosupplementation is performed for primary OA of a single knee.
`M17.12`	Unilateral primary osteoarthritis, left knee	As above, for the left knee.
`M17.9`	Osteoarthritis of knee, unspecified	General code used when laterality or primary/secondary distinction is not specified.
`M17.2`	Post-traumatic osteoarthritis of knee	Viscosupplementation may be used for symptomatic post-traumatic degenerative changes.
`M15.0`	Primary generalized (osteo)arthritis	In patients with multi-joint OA, individual knee injection may still be indicated.
`M19.90`	Osteoarthritis, unspecified site, unspecified	Less specific option when site coding is not available but a viscosupplement is administered for OA symptoms.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`20610`	Arthrocentesis, aspiration and/or injection; major joint or bursa (e.g., shoulder, hip, knee)	Primary procedure code used to report the intra-articular injection when viscosupplementation is administered into the knee.
`77002`	Fluoroscopic guidance for needle placement (eg, diagnostic or therapeutic injection), imaging supervision and interpretation; limited area	Report when fluoroscopic guidance is used to place the needle for the injection.
`76937`	Ultrasound guidance for needle placement (e.g., biopsy, aspiration, injection); first lesion	Report when ultrasound guidance is used for intra-articular needle placement.
`99212`	Office or other outpatient visit for the evaluation and management of an established patient, typically 10 minutes	Common E/M codes reported on the same day when a separate, identifiable visit occurs prior to the injection.
`99070`	Supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or procedure	Use to report additional nonstandard supplies associated with the injection when allowed by payor.
`J3301`	Triamcinolone acetonide, not otherwise specified, injectable suspension, 10 mg	Corticosteroid often used in conjunction with diagnostic or therapeutic joint injections; reported separately if administered in the same or different visit.

OpenPayer

Summary & Overview

HCPCS Q9980: Hyaluronan (Genvisc 850) for Intra-articular Injection, 1 mg